Back to search
FDAFDA · Food and drugs·Recall number D-0493-2019

Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Free, Non-staining Berry Flavor, 0.5 FL OZ (15 mL) bottle, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, UPC 0 50428 39338 3, NDC 59779-925-23.

Published February 20, 2019 · Recall initiated: January 15, 2019

Summary

FDA records drug Class II recall D-0493-2019, published February 20, 2019 and initiated January 15, 2019. Recalling firm: Tris Pharma Inc.; Status: Terminated; Reported quantity: 46,080 bottles; Lot: Lot#: 4718, Exp 12/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Tris Pharma Inc.
Distributor
One distributor who further distributed Nationwide in the USA.
Lot
Lot#: 4718, Exp 12/19
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Free, Non-staining Berry Flavor, 0.5 FL OZ (15 mL) bottle, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, UPC 0 50428 39338 3, NDC 59779-925-23. recalled?

Yes. FDA published recall D-0493-2019 on February 20, 2019. Reported hazard: Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.

What should I do if I have this product?

Voluntary: Firm initiated · Letter